The Cannabis Society Investor Conference - London (Invite Only)
HuckleTree, Alphabeta Building
18 Finsbury Square, Finsbury, London EC2A 1BR, UK
London
England
51.5215983
-0.08605820000002495
Description
*LIMITED SEATING, PLEASE REGISTER TO CONFIRM YOUR ATTENDANCE*
The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners and many more. Join us together with industry experts, entrepreneurs, investors and service providers as we discuss investing in cannabis, CBD and the current market trends in the medical cannabis industry across Europe.
The Cannabis Society hosts events across the globe including its New York Dinner of Influence, San Francisco Business Conference and Toronto Joint Venture Conference. For more about The Cannabis Society and our events click here.
CONFIRMED SCHEDULE:
10:30 - 10:55 AM:REGISTRATION
10:55 - 11:00 AM: OPENING REMARKS by The Cannabis Society
11:00 - 11:20 AM: KEYNOTE by Tom Zuber, Managing Partner, Zuber Lawler
11:20 - 11:40 AM: KEYNOTE by Nic Easley, CEO and Managing Director, Multiverse Capital™
11:40 - 12:00 PM:KEYNOTE by Steve Maxwell and Sage Ellie, Greenz.ca
BREAK
12:30 PM: Fireside Chat with Casa Verde Capital
Moderator: Sandrina Koemm-Benson, Editor-in-Chief, Leafly.de
Speaker:
Karan Wadhera, Managing Partner, Casa Verde Capital
1:00 PM: Marketing Cannabis In the UK & Europe Panel
Moderator: Sandrina Koemm-Benson, Editor-in-Chief, Leafly.de
Panelists:
Chris Tasker, Cannabis Consultant
Emanuel Kotzian, CEO Agentur Sowjet GmbH
Michael Fisher, Owner, Teeside Cannabis Club
1:30 PM: Startup Panel: Trials & Experiences Raising Capital
Moderator: Arnaud Dumas de Rauly, Co-Founder & CEO, The Blinc Group
Panelists:
Ed McDermott, Co Founder and Executive Director, Emmac
Dietwald Claus, CEO, Cannamerx
James Linden, CEO, Greenlight Medicines
BREAK
2:30 PM: Going Public Panel
Moderator: James Linden, CEO, Greenlight Medicines
Panelists:
Andy Morrison, Chairman, Spinnaker Opportunities PLC
Christian McFadden, CFO, Harmony
Melissa Sturgess, Chief Executive Officer, Ananda Developments Plc
3:00 PM: Raising Capital Panel
Moderator: Nic Easley CEO and Managing Director of Multiverse Capital™
Panelists:
Michael Garbuz, President & Co-Founder, Materia Ventures
Alex Brooks, Senior Analyst, Canaccord Genuity
Marc Brandl, European Representative, The Arcview Group
3:30 PM - Close: DEAL-MAKING
CONFIRMED PARTICIPANTS
Tom Zuber, Managing Partner of Zuber Lawler
Tom Zuber has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. Tom holds a law degree from Columbia Law School, a master’s degree in public policy from Harvard Government School, and a biomedical engineering degree from Rutgers University, where he graduated with highest honors.
Melissa Sturgess, Chief Executive Officer of Ananda Developments Plc
Melissa Sturgess holds a BSc and an MBA and has more than 20 years of experience as a director of UK and Australian Stock Exchange quoted companies, mainly involved in the acquisition, structuring and financing of natural resources deals across Africa. Miss Sturgess commenced her career in Australia as a member of the Executive Committee of Aquarius Platinum Limited, one of the first Australia/UK dual listed companies and a miner of platinum in South Africa and Zimbabwe. She was also founding director of Sylvania Resources Limited and a number of other companies operating in the metals and mining sector throughout Africa and listed on the AIM Market in London. Miss Sturgess relocated to London in 2006 and during her career has raised significant amounts of capital. She was a key driver in the successful recapitalisation of Messaging International plc during 2016 which subsequently changed its name to SigmaRoc Plc, acquired a building materials business via a reverse takeover and raised £50 million from a range of investors in the Channel Islands and the UK. Miss Sturgess’ interest in the cannabis sector started in 2017 with a trip to Israel to review the Medicinal Cannabis research that is happening in that country. She subsequently founded Ananda Developments to invest in the space and is its largest shareholder.
Deepak Anand CEO & Co-Founder Materia VenturesMr. Anand is recognized as a thought leader in the global cannabis space. He currently serves as the co-founder & CEO of Materia Ventures, a European-focused supply and distribution company for medical cannabis and CBD products. He previously served as vice president of business development and government relations at a Canadian cannabis consulting firm; vice president of a Health Canada-licensed producer; and as a board member for various pharmaceutical associations across Canada, the United States and Europe.
Nic Easley CEO and Managing Director of Multiverse Capital™
Nic Easley is a globally recognized cannabis industry expert and a sought-after writer, panelist, and keynote speaker for many top conferences and publications. He is the CEO and Managing Director of Multiverse Capital™, a cannabis venture firm, and the founder and CEO of 3C Consulting, LLC, the leading global strategic cannabis consulting firm. Nic and his team have traveled to 30 countries and 30 U.S. States and Territories working with over 300 cannabis companies across all sectors of the industry.
He is known for his passionate commitment to introducing demonstrated best practices from other industries into the cannabis space. His industry-leading track record of building strong cannabis businesses and guiding others towards their own victories has established him as a trusted and proven resource for anyone considering investing in the cannabis industry. Nic founded Multiverse Capital™ with his fellow Managing Director Skip Sanzeri to provide investors with unique access to deal flow and deep cannabis operational experience.
Nic serves on numerous state regulatory boards ranging from agriculture, public health and human safety, pesticides, and compliant business practices. He is also a committee or board member for multiple cannabis industry organizations, including as a Board Member for Americans for Safe Access (ASA). Nic recently educated delegates on medical cannabis at the UN Intergovernmental Expert Group Meeting on International Challenges Posed by the Non-Medical use of Synthetic Opioids.
Nic received a High Times Trail Blazer award in 2015 and was named one of the rising stars in cannabis investment by Business Insider in 2018. Nic is a Veteran of the United States Air Force and fluent in numerous languages holding degrees in both Environmental Studies and Biology. Nic’s scientific background combined with over 15 years of agricultural field and biological experience provides Multiverse Capital™ portfolio companies with new possibilities of productivity, profitability, and professionalism.
Michael Fisher, Owner of Teeside Cannabis Club
Despite starting life on the wrong side of the law, Michael battled his way through the impoverished estates of Teeside, to unleash his entrepreneurial streak. This first appeared in the form of a string of businesses in the local area before his father was unfortunately diagnosed with lung cancer. After witnessing first hand the medical benefits his late father derived from cannabis, and after treating his own Crohn’s disease with the plant, Michael became determined to challenge existing drug laws to ensure patients were no longer criminalized for the possession of cannabis. Since his father passing, Michael has been at the forefront of Medical cannabis activism opening his own Spanish style cannabis social club to develop the first cannabis social club model to be backed nationally by the police.
Marc Brandl - European Representative, The Arcview Group
Marc brings over 20 years experience in the cannabis sector. He is a co-founder of Students for Sensible Drug Policy and served as a project manager at the Marijuana Policy project in the late 90s.
After moving to a small village in Costa Rica Marc became a successful independent investor in startup and seed stage companies in renewable energy and cannabis. He was the first investor in Arcview Market Research (originally See Change Strategy). As an early investor and in his work with Arcview he has interacted with hundreds of companies across all verticals in the cannabis space.
Arcview Group is the first and largest of high net worth cannabis investors. Arcview members have placed more than $240 million in 200 ventures.
Marc now resides in Brussels, Belgium. He is excited to play a role in the fast paced development of the medical cannabis market in the European Union and Europe.
Emanuel Kotzian, CEO Agentur Sowjet GmbH
For more than twenty years Emanuel Kotzian dedicates himself to the education about the effects of marihuana and lobbies for the re-normalization of this classic cultural plant. In 2000 he established Germany's biggest Cannabis-Magazine “Hanf Journal” and founded Agentur Sowjet GmbH, where he currently serves successful as its CEO. With more than 1 million fans, followers and readers on several channels, Agentur Sowjet is one of the leading marketing companies on the European Hemp Market. Its network of companies and branch offices extends from the Canary Islands to Kiev in the Ukraine and represents a unique platform for any market participant. Emanuel Kotzian was born 1972 in Krakow and immigrated with his family to Germany where he became a professing World-Citizen. After finishing High School in 1992 he studied Economics. Partly he was serving at a German court as a commercial judge, what did not stop him to get engaged into local politics. Now he is deeply involved in the promotion and up rise of CBD-Products, what he believes is a very important key for making hemp a normal and accepted natural product again."
Andy Morrison, Chairman of Spinnaker Opportunities PLC
Andy is Chairman of Spinnaker Opportunities Plc, which is a Special Purpose Acquisition Company (SPAC) or cash shell quoted on the main board of the London Stock Exchange. In September 2018, Spinnaker extended its investment strategy to include acquisition targets in the emerging European cannabis industry. In February 2019 the Company announced its intention to acquire Kanabo Research Ltd, a company engaged in the formulation of cannabis oils using technology originated in Israel and their application through medically approved vaporization devices. All being well, the transaction will close later this year, thereby creating one of the first publicly listed operating cannabis businesses in London.
Karan Wadhera, Managing Partner, Casa Verde CapitalKaran Wadhera is the Managing Partner at Casa Verde Capital, the leading venture capital firm in the cannabis industry. Karan leads the team across investment strategy, fundraising, and portfolio management; he also sits on the board of 11 cannabis companies.During his tenure at Casa Verde, Karan has been responsible for raising the $45mm fund and deploying across 15 portfolio companies, which have collectively raised over $250mm in funding. As an established thought leader in the space, Mr. Wadhera has been featured in numerous mainstream press outlets and conferences, including the Milken Global Conference, CNBC, Bloomberg, TechCrunch, Financial Times, and more. Prior to Casa Verde, Mr. Wadhera held senior roles at Goldman Sachs and Nomura, in both domestic and international markets such as New York, Hong Kong, and Mumbai. While in India, Karan was part of the founding team of Goldman’s India Equities business. Furthermore, Karan is an active private investor and advisor to a number of young companies around the world; he co-founded MissMalini.com, one of the India's most well-known digital media and entertainment brands. Similarly, Karan was an early investor in Steadview, which is now one of the largest India dedicated hedge funds in the world. Karan is a Boston native and received his BA from Babson College.Alex Brooks, Senior Analyst Canaccord Genuity
Alex Brooks is a senior analyst at Canaccord Genuity, covering UK-listed materials technology, energy services, and medical cannabis companies. He has covered a wide range of industrial & energy companies over twenty years in the City, working on projects from large-scale emerging market IPOs to small secondary fundraises. He started his career at JPMorgan Asset Management, and has also worked sell-side at UBS & Credit Suisse.
James Linden, GreenLight Medicines
James achieved his PhD in Biochemistry in the Department of Ophthalmology, Queens University Belfast. After a year of researching Alzheimer’s Diseases as a Post-Doc in Neuroscience, Trinity College Dublin, James left the academic world and moved into pharmaceutical sales. After gaining sales experience he then went on to form his own generic drug company in Ireland called Éireceutica Ltd. Here he learned many skills and attributes which he has carried forth into his latest brain-child, GreenLight Medicines. As a scientist and a pharma veteran James had the perfect skill set to build GreenLight’s world-beating research network and also to identify which products should be developed and which markets they should be developed for. Since developing GreenLight James and colleagues have formed two further pharmaceutical companies. The first is focused on developing medicines from psychedelic plant medicines and has a molecule moving into Phase 1 human trials as a treatment for addiction. The second is a University College Dublin spin-out called Reneurex R&D which has a candidate for remyelination in Multiple Sclerosis moving into Phase 2 clinical trials. James has a deep knowledge of all things cannabis, from cultivation, through sales, regulations, clinical trials to fund-raising.
Sandrina Koemm-Benson, Editor-in-Chief, Leafly.de
Sandrina Koemm-Benson is the editor-in-chief of Leafly.de since the launch in May 2017. The 45-year-old trained editor with a bachelor's degree in marketing has a very close personal connection to the subject of medical cannabis. Therefore, after nearly 20 years working in the media and PR business, she dropped her own agency and joined Leafly.de. Since the launch of Leafly.de in May 2017, she has been an advocate for patients and a recognized contact for physicians and industry representatives. She has built up an extensive international network in all directions and has a lot of insider knowledge. Under her editorial guidance, Leafly.de has become the leading knowledge portal on cannabis as a medicine in the German-speaking European countries. With more than 300,000 visitors per month, the independent online portal is the number one source of information for physicians, patients and healthcare professionals. As an expert, she is often on the road to educate and inform people about the topic. Leafly.de is the German representation of Leafly.com which is considered to be the largest cannabis knowledge base worldwide.
Christian McFadden, CFO, Harmony
Christian is the CFO of Harmony, an international wellness company using hemp as a tool to bring real harmony to people’s lives. With 40 employees and a distribution network of more than 3100 retailers, Harmony transforms the potential of nature into beloved products all over the world.
Christian’s spent most of his career in the finance and proptech sectors, including 9 years in London investing in loan portfolios and hedge funds, and 3 years of investment banking at Goldman Sachs in NY. Christian earned his AB in Economics from Princeton, and his MBA from Stanford.
He is an expert in European CBD regulation and cannabis business valuation across various markets and company sizes. Christian has invested in deals worth more than €750m throughout his career.
Dietwald Claus, Founder and CEO, Cannamerx
Dietwald Claus is a public affairs professional with deep expertise in the Canadian food and agriculture regulatory system, as well crisis communications, standards development, and trade policy.He has worked for industry associations and consulting services since 2000. In 2016, Dietwald decided to combine his experience in dealing with highly regulated industries with his background in agricultural economics to create Cannamerx, the first fully automated B2B trading platform for the legal cannabis industry inCanada and internationally.
Ed McDermott, Co-Founder & Director, ENMAC Life Sciences
Ed McDermott is an experienced capital markets professional with 15 years’ expertise in the management and financing of growth companies internationally.
He has been pivotal in raising over £500m in equity for growth companies and is currently a Director of AIM quoted FastForward Innovations Ltd, a VC that has a track record of successful investment in the medical cannabis sector. He is also Non-Executive Chairman of Emmerson Plc, a Moroccan Potash development company listed on the London Stock Exchange.
Ed has been actively involved in the medical cannabis promotion and discussion with UK and European policy makers and advocacy groups.
Arnaud Dumas de Rauly, Co-founder & Co-CEO, The Blinc Group
Arnaud is currently Co-Founder and Co-CEO of The Blinc Group. He is a proven leader of multiple start-up companies who simultaneously leads, guides, directs and evaluates operations through international marketing, communication & public relations. Bilingual in French and English, fluent in Spanish and has worked in France, China, Dubai, Tunisia, Spain, UK and the USA. Frequently serves as a keynote speaker at international vaping and cannabis shows across the globe. Arnaud holds an Executive MBA & a Masters of Engineering Degrees. Arnaud is also Chairman of the ISO (International) Standards Committee TC126/SC3on Vapor Products & of the CEN (European) Standards Committee (TC427) on Vapor Products. He is also is the former President of FIVAPE, a French vaping trade association and now serves as the organization's Secretary General for International Relations.
More information coming soon...
Gold Partners:
UPCOMING CANNABIS CONFERENCES
Can't join us for this conference? Check out our upcoming conferences:
June 26th - San Francisco Joint Venture Conference
June 26th - San Francisco Marketplace Conference
June 28th - Los Angeles Investor Conference
September 23 - Berlin Joint Venture Conference
This listing has no upcoming events
Start:
2019-06-25T10:30:00+01:00
End:
2019-06-25T16:00:00+01:00
Category
Business
Tickets
Early Bird
49.0
GBP
20
General Admission
99.0
GBP
40
Presenter Package
1.5e3
GBP
4